Health ❯Healthcare ❯Chronic Diseases

Diabetes

Type 2 Diabetes Treatment Options GLP-1 Agonists Management Strategies Weight Loss Medications Insulin Therapy Medications Prediabetes Brain Health Type 2 Diabetes Treatment Tzield Type 2 Diabetes in Adolescents Nutrition Weight Loss Treatments Heart Disease Chronic Kidney Disease Diabetes Management GLP-1 Receptor Agonists GLP-1 Medications

Novo Nordisk's CagriSema Falls Short in Latest Weight-Loss Trial for Diabetes Patients

FDA Approves Ozempic for Chronic Kidney Disease in Type 2 Diabetes Patients

Study Highlights Benefits and Risks of Popular Weight-Loss Drugs

GLP-1 Drugs Revolutionize Prescriptions and Broader Health Applications

U.S. Leads World in Years Spent in Poor Health Despite Longer Lifespans

Cost and Efficacy Concerns Arise for GLP-1 Weight Loss Drugs

Novo Nordisk's Oral Semaglutide Shows 14% Reduction in Heart Risks

Semaglutide Shows Promise in Reducing Opioid Overdose Risk, Study Finds

New Research Highlights Key Factors for Effective Weight Loss with GLP-1 Drugs

New Studies Confirm Safety of Semaglutide for Mental Health

Type 2 Diabetes Drug Shows Potential to Lower Dementia Risk by 35%

Healthy Lifestyle May Mitigate Diabetes-Induced Brain Aging

Researchers Develop 'Smart Insulin' for Improved Diabetes Management

NHS 'Soup and Shake' Diet Shows Promise in Reversing Type 2 Diabetes

Eli Lilly's Zepbound Shows Promise in Reducing Heart Failure Risks

Semaglutide Drugs Show Potential Beyond Weight Loss

GLP-1 Drug Shows Promise in Slowing Alzheimer's Cognitive Decline

Ozempic's Expanding Role: Beyond Diabetes and Weight Loss